Carbobenzyloxy-Val-Ala-Asp-alpha-fluoromethylketone structure
|
Common Name | Carbobenzyloxy-Val-Ala-Asp-alpha-fluoromethylketone | ||
|---|---|---|---|---|
| CAS Number | 161401-82-7 | Molecular Weight | 453.461 | |
| Density | 1.3±0.1 g/cm3 | Boiling Point | 758.0±60.0 °C at 760 mmHg | |
| Molecular Formula | C21H28FN3O7 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | 412.2±32.9 °C | |
Use of Carbobenzyloxy-Val-Ala-Asp-alpha-fluoromethylketoneZ-VAD-FMK (Z-VAD(OH)-FMK) is a well-know pan caspase inhibitor, which does not inhibit ubiquitin carboxy-terminal hydrolase L1 (UCHL1) activity even at concentrations as high as 440 μM[1]. |
| Name | (3S)-5-fluoro-3-[[(2S)-2-[[(2S)-3-methyl-2-(phenylmethoxycarbonylamino)butanoyl]amino]propanoyl]amino]-4-oxopentanoic acid |
|---|---|
| Synonym | More Synonyms |
| Description | Z-VAD-FMK (Z-VAD(OH)-FMK) is a well-know pan caspase inhibitor, which does not inhibit ubiquitin carboxy-terminal hydrolase L1 (UCHL1) activity even at concentrations as high as 440 μM[1]. |
|---|---|
| Related Catalog | |
| Target |
Caspase |
| In Vitro | Z-VAD-FMK (40 μM) reverses the apoptotic effect exerted by total saponin of Solanum lyratum Thunb (TSSLT) in Hela cells. HeLa cells are pretreated with Z-VAD-FMK (40 μM) for 30 min and exposed to TSSLT (6 μg/mL) for 48 h[2]. Cell Viability Assay[2] Cell Line: HeLa cells Concentration: 40 μM Incubation Time: Prtreated for 30 minutes Result: Prevented TSSLT-induced cell death. More than 80% cell survival was observed. |
| References |
| Density | 1.3±0.1 g/cm3 |
|---|---|
| Boiling Point | 758.0±60.0 °C at 760 mmHg |
| Molecular Formula | C21H28FN3O7 |
| Molecular Weight | 453.461 |
| Flash Point | 412.2±32.9 °C |
| Exact Mass | 453.191132 |
| PSA | 161.37000 |
| LogP | 3.04 |
| Vapour Pressure | 0.0±2.7 mmHg at 25°C |
| Index of Refraction | 1.525 |
| Hazard Codes | Xi |
|---|
| Z-VAD-FMK,Non-methylated |
| Z-Val-Ala-Asp-FMK |
| Caspase Inhibitor VI |
| N-[(Benzyloxy)carbonyl]-L-valyl-N-[(2S)-1-carboxy-4-fluoro-3-oxo-2-butanyl]-L-alaninamide |
| L-alaninamide,N-[(phenylmethoxy)carbonyl]-L-valyl-N-[(1S)-1-(carboxymethyl)-3-fluoro-2-oxopropyl] |
| (3S)-3-[(2S)-2-[(2S)-2-{[(benzyloxy)carbonyl]amino}-3-methylbutanamido]propanamido]-5-fluoro-4-oxopentanoic acid |
| L-Alaninamide, N-[(phenylmethoxy)carbonyl]-L-valyl-N-[(1S)-1-(carboxymethyl)-3-fluoro-2-oxopropyl]- |
| N-[(benzyloxy)carbonyl]-L-valyl-N-[(2S)-1-carboxy-4-fluoro-3-oxobutan-2-yl]-L-alaninamide |